glipizide has been researched along with Ventricular Dysfunction in 1 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leonard, CE | 1 |
| Brensinger, CM | 1 |
| Aquilante, CL | 1 |
| Bilker, WB | 1 |
| Boudreau, DM | 1 |
| Deo, R | 1 |
| Flory, JH | 1 |
| Gagne, JJ | 1 |
| Mangaali, MJ | 1 |
| Hennessy, S | 1 |
1 other study available for glipizide and Ventricular Dysfunction
| Article | Year |
|---|---|
Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.
Topics: Aged; Arrhythmias, Cardiac; Cause of Death; Death, Sudden, Cardiac; Diabetic Angiopathies; Female; G | 2018 |